Variablea | non-RSCL (n = 162) | RSCL (n = 53) | p-valueb |
---|---|---|---|
Male gender | 94 (58.0 %) | 29 (54.7 %) | 0.6727 |
Race & Ethnicity: | |||
White | 128 (79.0 %) | 46 (86.8 %) | 0.2107 |
Black | 27 (16.7 %) | 6 (11.2 %) | 0.3486 |
Age, years | 61 (17) | 64 (13) | 0.2336 |
Age (≥70) | 55 (34.0 %) | 19 (35.9 %) | 0.8006 |
Comorbidities: | |||
Number comorbidities, average | 1.9 (2.2) | 2.2 (2.8) | 0.4641 |
No comorbidities | 71 (43.8 %) | 23 (43.4 %) | 0.9562 |
1 comorbidity | 19 (11.7 %) | 2 (3.8 %) | 0.0904 |
2 comorbidities | 14 (8.6 %) | 7 (13.2 %) | 0.3311 |
≥3 comorbidities | 58 (35.8 %) | 21 (39.6 %) | 0.6166 |
Inflammatory status preoperatively: | |||
No inflammation | 75 (46.3 %) | 10 (18.9 %) | 0.0004 |
Sepsis | 59 (36.4 %) | 28 (52.8 %) | 0.0346 |
Severe sepsis/septic shock | 28 (17.3 %) | 15 (28.3 %) | 0.0817 |
Lethal Triad: | |||
Hypothermia (temp ≤ 35C) | 24 (16.8 %) | 7 (14.9 %) | 0.7610 |
Coagulopathy (INR ≥ 1.7) | 13 (11.1 %) | 9 (18.4 %) | 0.2085 |
Acidosis (pH ≤ 7.25) | 24 (22.2 %) | 18 (35.3 %) | 0.0810 |
Patient characteristics: | |||
ASA score, average | 3 (1) | 4 (1) | <0.0001 |
ASA score, 1 or 2 | 23 (14.2 %) | 0 (0.0 %) | 0.0015 |
ASA score, 3 | 65 (40.1 %) | 8 (15.1 %) | 0.0008 |
ASA score, 4 or 5 | 74 (45.7 %) | 45 (84.9 %) | <0.0001 |
Lactate (≥3) | 32 (33.3 %) | 26 (51.0 %) | 0.0372 |